Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies

Sonali R. Gnanenthiran; Vivekanand Jha; Abdul Salam; Emily Atkins; Clara K. Chow; Mark R. Nelson; Mike Rakotz; Markus P. Schlaich; Aletta E. Schutte; Tim Usherwood; Anthony Rodgers

doi:10.1038/s41371-023-00816-y

Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies

Sonali R. Gnanenthiran, Vivekanand Jha, Abdul Salam, Emily Atkins, Clara K. Chow, Mark R. Nelson, Mike Rakotz, Markus P. Schlaich, Aletta E. Schutte, Tim Usherwood, Anthony Rodgers

Internal Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

In a first of its kind assessment in cardiovascular research, we assessed whether pooled cardiovascular expertise could accurately predict efficacy and tolerability for both a novel and an established treatment option. A survey was administered prior to the publication of the QUARTET (A Quadruple UltrA-low-dose tReatment for hypErTension) trial. QUARTET was a multicentre, double-blind, parallel-group, trial that randomised participants to initial treatment with either monotherapy or an ultra-low dose quadruple single pill combination for 12 weeks. Survey participants were asked to predict blood pressure (BP) at 12 weeks and 52 weeks for both groups.

Original language	English
Pages (from-to)	422-424
Number of pages	3
Journal	Journal of Human Hypertension
Volume	37
Issue number	5
DOIs	https://doi.org/10.1038/s41371-023-00816-y
Publication status	Published - May 2023

Access to Document

10.1038/s41371-023-00816-yLicence: CC BY

Cite this

Gnanenthiran, S. R., Jha, V., Salam, A., Atkins, E., Chow, C. K., Nelson, M. R., Rakotz, M., Schlaich, M. P., Schutte, A. E., Usherwood, T., & Rodgers, A. (2023). Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies. Journal of Human Hypertension, 37(5), 422-424. https://doi.org/10.1038/s41371-023-00816-y

@article{7c1fc5ea01b245728b16d9cd730f91ed,

title = "Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies",

abstract = "In a first of its kind assessment in cardiovascular research, we assessed whether pooled cardiovascular expertise could accurately predict efficacy and tolerability for both a novel and an established treatment option. A survey was administered prior to the publication of the QUARTET (A Quadruple UltrA-low-dose tReatment for hypErTension) trial. QUARTET was a multicentre, double-blind, parallel-group, trial that randomised participants to initial treatment with either monotherapy or an ultra-low dose quadruple single pill combination for 12 weeks. Survey participants were asked to predict blood pressure (BP) at 12 weeks and 52 weeks for both groups.",

author = "Gnanenthiran, {Sonali R.} and Vivekanand Jha and Abdul Salam and Emily Atkins and Chow, {Clara K.} and Nelson, {Mark R.} and Mike Rakotz and Schlaich, {Markus P.} and Schutte, {Aletta E.} and Tim Usherwood and Anthony Rodgers",

year = "2023",

month = may,

doi = "10.1038/s41371-023-00816-y",

language = "English",

volume = "37",

pages = "422--424",

journal = "Journal of Human Hypertension",

issn = "0950-9240",

publisher = "Nature Publishing Group - Macmillan Publishers",

number = "5",

}

TY - JOUR

T1 - Wisdom of the Crowd

T2 - insights gained from comparing predicted and observed effects of blood pressure lowering strategies

AU - Gnanenthiran, Sonali R.

AU - Jha, Vivekanand

AU - Salam, Abdul

AU - Atkins, Emily

AU - Chow, Clara K.

AU - Nelson, Mark R.

AU - Rakotz, Mike

AU - Schlaich, Markus P.

AU - Schutte, Aletta E.

AU - Usherwood, Tim

AU - Rodgers, Anthony

PY - 2023/5

Y1 - 2023/5

N2 - In a first of its kind assessment in cardiovascular research, we assessed whether pooled cardiovascular expertise could accurately predict efficacy and tolerability for both a novel and an established treatment option. A survey was administered prior to the publication of the QUARTET (A Quadruple UltrA-low-dose tReatment for hypErTension) trial. QUARTET was a multicentre, double-blind, parallel-group, trial that randomised participants to initial treatment with either monotherapy or an ultra-low dose quadruple single pill combination for 12 weeks. Survey participants were asked to predict blood pressure (BP) at 12 weeks and 52 weeks for both groups.

AB - In a first of its kind assessment in cardiovascular research, we assessed whether pooled cardiovascular expertise could accurately predict efficacy and tolerability for both a novel and an established treatment option. A survey was administered prior to the publication of the QUARTET (A Quadruple UltrA-low-dose tReatment for hypErTension) trial. QUARTET was a multicentre, double-blind, parallel-group, trial that randomised participants to initial treatment with either monotherapy or an ultra-low dose quadruple single pill combination for 12 weeks. Survey participants were asked to predict blood pressure (BP) at 12 weeks and 52 weeks for both groups.

UR - http://www.scopus.com/inward/record.url?scp=85152641949&partnerID=8YFLogxK

U2 - 10.1038/s41371-023-00816-y

DO - 10.1038/s41371-023-00816-y

M3 - Article

C2 - 37041253

AN - SCOPUS:85152641949

SN - 0950-9240

VL - 37

SP - 422

EP - 424

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

IS - 5

ER -

Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies

Abstract

Access to Document

Other files and links

Fingerprint

Cite this